Skip to main content
Clinical Trials/NL-OMON21453
NL-OMON21453
Recruiting
N/A

Dopaminergic Functioning in Autism Spectrum Disorder

GGZ Rivierduinen Leiden, Leiden University Medical Center (LUMC), Maastricht University0 sites69 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism Spectrum DisorderAutisme Spectrum StoornisSocial DefeatSocial ExclusionSociale UitsluitingPsychosisPsychoseDopamine
Sponsor
GGZ Rivierduinen Leiden, Leiden University Medical Center (LUMC), Maastricht University
Enrollment
69
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
GGZ Rivierduinen Leiden, Leiden University Medical Center (LUMC), Maastricht University

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients: DSM\-5 diagnosis of Autism Spectrum Disorder.
  • 2\. Age: 18\-30 years.

Exclusion Criteria

  • 1\. Healthy controls: DSM\-5 diagnosis of Autism Spectrum Disorder.
  • 2\. Autism Spectrum Disorder due to a known organic disorder (¡°Syndromal ASD¡±, e.g., due to Fragile X syndrome, Klinefelter syndrome, 22q11 deletion syndrome).

Outcomes

Primary Outcomes

Not specified

Similar Trials